90mg Tablet
Brand / Label: AstraZeneca
| Generic Composition | Ticagrelor (90mg) |
| Packaging Metrics | 14 strip (14 units / pack) |
| Administration Route | Oral |
| Regulatory Schedule | Prescription Required (Schedul |
Brilinta 90mg Tablet contains Ticagrelor 90 mg, an antiplatelet medicine used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with acute coronary syndrome (ACS), previous myocardial infarction (heart attack), or after coronary stent placement. It helps prevent blood clots by reducing platelet aggregation and is commonly prescribed together with low-dose aspirin unless otherwise directed by the treating physician.
Prevention of heart attack (Myocardial Infarction) Prevention of ischemic stroke Acute Coronary Syndrome (ACS) Unstable Angina After Coronary Angioplasty (PCI/PTCA) Prevention of stent thrombosis
Take exactly as prescribed by your doctor.
Swallow the tablet whole with water.
Can be taken with or without food.
Usually prescribed together with low-dose aspirin.
Do not discontinue treatment without medical advice, as this may increase the risk of serious cardiovascular events.
No general physiological alerts logged.
None explicitly declared.
Standard verification parameters match.
Common: Negglygible side effects registered.
No specific nutritional constraints recorded.
| Pregnancy | Lactation | Pediatric Cohorts | Geriatric Cohorts |
|---|---|---|---|
| Consult your practitioner. | Consult your practitioner. | Standard safety indices apply. | Standard dose matching applies. |
No unique safety flags logged.
Standard renal clearance indices.
Standard hepatic metabolism indices.
No patient evaluation data has been logged for this metric yet.